Stock Updates

Today’s Top Gainers in the Market Amgen Inc. (NASDAQ:AMGN) from Healthcare

Today’s top gainers include the company Amgen Inc. (NASDAQ:AMGN) which is in the industry Biotechnology, gaining -0.12% today. In the last week its performance is -0.08%, and 8.62% for the past quarter. Currently, Amgen Inc., AMGN has a target price of 191, so today’s gain of -0.12% is a significant step towards its target price. The GAP today is therefore -0.62%.

Amgen Inc. (NASDAQ:AMGN), has a market cap of 127963.97, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 81.10%.

At the current price of 170.63, it has a dividend yield of 2.34%, and its target price is 191. This is with a profit margin of 33.10%, and total debt/equity of 1.1. Amgen Inc. (NASDAQ:AMGN) has a P/E of 17.46, as well as a forward P/E of 13.66.

With a current EPS of 9.77, and a forecasted EPS growth for next year at 9.91%,Amgen Inc. (NASDAQ:AMGN) has had a EPS growth for the past five years at 13.60%. For the next five years EPS growth is projected to be 7.93%.

Performance for the year is 13.12%. Since its IPO date on 9/7/1984, the total performance to date is 7.16%.

Volume today for Amgen Inc. (NASDAQ:AMGN), is 2013000, while its average volume is 2891.83. Whilst the total gain today was -0.12%, it did have a day high of -3.40%.

Volatility for this week has been at 1.21%, and 1.40% for the month. The 52-week low for Amgen Inc., AMGN has been 34.39%, while the 52-week-high has reached -3.40%.

Looking at its return of investments, which is 12.50%, and its return on assets is 10.10%. Amgen Inc. (NASDAQ:AMGN) has an operating margin of 40.70%. With a sales growth of 5.90% quarter over quarter. Bearing in mind that Amgen Inc., AMGN is in the sector Healthcare, its long-term debt/equity is 0.93, and has a current ratio of 4 and 3.7 for quick ratio.

So what is the value of Amgen Inc.? Well its PEG is 2.2, and the P/S is 5.69, along with a P/B of 4.25. Meanwhile it has a p/cash of 3.65.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment